Skip to content
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
Menu
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
accuray-logo-20
  • Who We Are
    • –
  • Resources
    • –
  • Products
    • –
  • Services
    • –
Menu
  • Who We Are
    • –
  • Resources
    • –
  • Products
    • –
  • Services
    • –
Search
Close
accuray-logo-20.svg

Date: 2022

Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy

Salvestrini V, Duijm M, Loi M, Nuyttens JJ | Cancers (Basel) | 2022

Lung Sparing and Ribcage Coverage in Total Body Irradiation Delivered by Helical TomoTherapy

Köksal M, Baumert J, Schoroth F, Scafa D, Koch D, Leitzen C, Sarria GR, Giordano FA, Chatzikonstantinou G, Schmeel LC | Eur J Med Res | 2022

Clinical study of total bone marrow combined with total lymphatic irradiation pretreatment based on tomotherapy in hematopoietic stem cell transplantation of acute leukemia

Fanyang Kong, Shuaipeng Liu, Lele Liu, Yifei Pi, Yuntong Pei, Dandan Xu, Fei Jia, Bin Han, Yuexin Guo | Front Oncol | 2022

Conventionally fractionated radiotherapy versus CyberKnife hypofractionated radiotherapy for painful vertebral haemangiomas – A randomized clinical trial

Marcin Miszczyk, Aleksandra Napieralska, Grzegorz Woźniak, Małgorzata Kraszkiewicz, Michał Gola, Michał Kalemba, Grzegorz Głowacki, Bartłomiej Tomasik, Magdalena Kocot-Kępska, Leszek Miszczyk | Radiother Oncol | 2022

Outcomes of fractionated CyberKnife radiosurgery in patients with choroidal malignant melanoma

Ceyda Baskan, Ebru Atasever Akkas, Sabite Emine Gökce, Sibel Ozdogan | Acta Oncol | 2022

2486: Correlation between Obesity and Treatment Failure Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer

D. Conroy, T. Sholklapper, M. K. K. Lawlor, J. M. Cantalino, A. Zwart, M. J. Ayoob, M. Danner, T. Yung, B. T. Collins, S. Lei, A. Rashid, D. Kumar, S. Suy, N. Aghdam, and S. P. Collins | ASTRO | 2022

194: Penile Bulb Dose Predicts Sexual Quality of Life after Prostate SBRT: Secondary Analysis of a Multi-Institutional Trial

K. P. Lui, K. Wang, R. C. Chen, B. L. Kane, C. A. Medbery III, K. Underhill Jr, J. R. Gray, A. V. Peddada, and D. B. Fuller | ASTRO | 2022

2026: Efficacy of SBRT in High Volume Metastatic Carcinoma Breast – A Berry Picking Approach in the Era of High Precision Radiotherapy

P.S. Sridhar, P. Anuradha, C. Fareena Taj, S. Suresh, K. Roopesh, R. Ghosh, S. Bj, | ASTRO | 2022

Hypofractionated Stereotactic Radiotherapy with or without Whole Brain Radiotherapy with Helical Tomotherapy for Multiple Brain Metastases – Long-Term Follow-Up Results of a Phase II Trial

  Yuchao Ma | ASTRO | 2022

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]

Optimized Conformal Total Body Irradiation methods with Helical TomoTherapy and Elekta VMAT: Implementation, Imaging, Planning and Dose Delivery for Pediatric Patients

Loginova AA, Tovmasian DA, Lisovskaya AO, Kobyzeva DA, Maschan MA, Chernyaev AP, Egorov OB, and Nechesnyuk AV | Front Oncol | 2022

ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children

Hoeben BAW, Pazos M, Seravalli E, Bosman ME, Losert C, Albert MH, Boterberg T, Ospovat I, Mico Milla S, Abakay CD, Engellau J, Johansson V, Kos G, Supiot S, Llagostera C, Bierings M, Scarzello G, Seiersen K, Smith E, Ocanto A, Ferrer C, Bentzen SM, Kobyzeva DA, Loginova AA, and Janssens GO | Radiother Oncol […]

Influencing Factors of Total Skin Irradiation With Helical Tomotherapy

Wang H, Pi Y, Guo Y, Pei X, and Xu XG | Front Oncol | 2022

Pediatric Craniospinal Irradiation – The implementation and Use of Normal Tissue Complication Probability in Comparing Photon versus Proton Planning

Balasubramanian S, and Shobana MK | J Med Phys | 2022

Technical Note: Comprehensive performance tests of the first clinical real-time motion tracking and compensation system using MLC and jaws

Chen GP, Tai A, Keiper TD, Lim S, Li XA | Med Phys | 2020

Characterization of imaging performance of a novel helical kVCT for use in image-guided and adaptive radiotherapy – PubMed (nih.gov)

Tegtmeier RC, Ferris WS, Bayouth JE, Miller JR, and Culberson WS | J Appl Clin Med Phys | 2022

Robotic CyberKnife radiosurgery for small choroidal melanomas – PubMed (nih.gov)

Valerie Schmelter, Theresa Hofmann, Frederick Schneider, Constance Weber, Christoph Fuerweger, Alexander Muacevic, Siegfried G Priglinger, Paul Foerster, Raffael Liegl | Melanoma Res | 2022

Feasibility of postoperative spine stereotactic body radiation therapy in proximity of carbon and titanium hybrid implants using a robotic radiotherapy device

Dominik Henzen, Daniel Schmidhalter, Gian Guyer, Anna Stenger-Weisser, Ekin Ermiş, Robert Poel, Moritz Caspar Deml, Michael Karl Fix, Peter Manser, Daniel Matthias Aebersold, Hossein Hemmatazad | Radiat Oncol | 2022

The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy

Cheng YK, Kuo SH, Yen HH, Wu JH, Chen YC, and Huang MY | Radiat Oncol | 2022

Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and tomotherapy for advanced cervical cancer – PubMed (nih.gov)

Li D, Wang D, Feng S, Chen Q, Sheng X, Jia J, Yan X, Zhu J, and Yin Y | Oncol Lett | 2022

← older
Facebook-f Linkedin Twitter Youtube
  • CyberKnife®
  • Radixact®
  • TomoTherapy®
  • Accuray Precision® Treatment Planning
  • iDMS® Data Management
  • CyberKnife®
  • Radixact®
  • TomoTherapy®
  • Accuray Precision® Treatment Planning
  • iDMS® Data Management
  • Careers
  • Services
  • Patients
  • Investors
  • Contact Us
  • Careers
  • Services
  • Patients
  • Investors
  • Contact Us
  • Conflict Minerals Policy Statement
  • Privacy Policy
  • Terms of Use
  • EthicsPoint Hotline
  • Cookie Use Notice
  • India eWaste Management Program
  • Trademarks
  • Conflict Minerals Policy Statement
  • Privacy Policy
  • Terms of Use
  • EthicsPoint Hotline
  • Cookie Use Notice
  • India eWaste Management Program
  • Trademarks

Safety Statement for Radiation Treatment:
Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death. Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient’s general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.

© 2023 Accuray Incorporated, All Rights Reserved. The stylized Accuray logo, CyberKnife, VSI, M6, TomoTherapy, H Series, Tomo, TomoH, TomoHD, TomoHDA, TomoEDGE, TomoHelical, TomoDirect, Hi·Art, PlanTouch, PreciseART, PreciseRTX, Radixact, Accuray Precision, iDMS, Iris, Xchange, RoboCouch, InCise, MultiPlan, Xsight, Synchrony, InTempo, TxView, PlanTouch, QuickPlan, TomoHelical, TomoDirect, TomoEDGE, CTrue, ClearRT, VoLO, Planned Adaptive, TQA, TomoLink, TomoPortal, OIS Connect and AERO are trademarks or registered trademarks of Accuray Incorporated, in the United States and other countries and may not be used or distributed without written authorization from Accuray Incorporated. Use of Accuray Incorporated’s trademarks requires written authorization from Accuray Incorporated.

  • Home
  • AI Real-time Tracking
  • Hypofractionation Trend
  • 20+ Years of Evidence
  • Adaptation in Action
  • CyberKnife® S7™
  • Radixact®
  • Home
  • AI Real-time Tracking
  • Hypofractionation Trend
  • 20+ Years of Evidence
  • Adaptation in Action
  • CyberKnife® S7™
  • Radixact®
Who we are
  • Company
  • Leadership
  • Careers
  • Locations
  • News
  • Media
  • Events
  • Partners
  • Investors
Resources

  • 20+ Years of Evidence
  • Blog
  • Innovation
  • Case Studies
  • Patients
  • Product Resources
  • Veterinary Oncology
  • Cybersecurity

Treatment Centers

Find a Facility Near You

Products
  • Overview
  • Entrega do Tratmento
  • Resources
  • Overview
  • Entrega do Tratmento
  • Resources
  • Overview
  • Entrega do Tratamento
  • Resources
  • Accuray Precision® Treatment Planning
  • PreciseART®
  • PreciseRTX®
  • iDMS® Data Management
  • Synchrony®
  • RayStation®
  • RayCare®
Services
  • Service Overview
  • Site Planning and Installation
  • Training
  • CyberKnife®
  • Radixact®
  • Technology Upgrades
  • Service Support
  • Customer Resources
  • AERO™ Community
  • Service Requests
  • Contact Us
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
  • English

Unmatched service to protect uptime and maximize ROI

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

  • Service Overview
  • Site Planning And Installation
  • Training
  • CyberKnife®
  • Radixact®
  • Alliance Advances
  • Service Support
  • Customer Resources
  • Contact
  • Overview
  • Treatment Delivery
  • Resources
  • Overview
  • Treatment Delivery
  • Resources
  • Overview
  • Treatment Delivery
  • Resources
  • Accuray Precision® Treatment Planning
  • PreciseART®
  • PreciseRTX®
  • iDMS® Data Management
  • Synchrony®
  • RayStation®
  • RayCare®

Redefining the future of cancer care

Learn how Accuray radiation technologies enable clinicians to get patients back to living their lives, faster. Explore coming innovations that unlock entirely new possibilities.

Treatment Centers

Find a Facility Near You
  • 20+ Years of Evidence
  • Blog
  • Innovation
  • Case Studies
  • Patients
  • Product Resources
  • Veterinary Oncology
  • Cybersecurity

Accuray treatment options

The following pages explore some of the many ways clinicians around the globe use Accuray technologies to deliver unique and effective treatments for a wide range of clinical indications.

Treatment Centers

Find a Facility Near You

Breast

  • IMRT with TomoHelical™
  • 3DCRT with TomoDirect™

Intracranial

  • SRS with CyberKnife ®

Prostate

  • SBRT with CyberKnife®

Lung

  • SBRT with CyberKnife®

Head and Neck

  • IMRT with TomoHelical™

Veterinary

  • Veterinary Oncology with
    CyberKnife® & TomoTherapy®

About Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.

  • Company
  • Leadership
  • Careers
  • Locations
  • News
  • Media
  • Corporate Citizenship
  • Events
  • Partners
  • Investors